Skip to main content
PLOS One logoLink to PLOS One
. 2023 Apr 13;18(4):e0284542. doi: 10.1371/journal.pone.0284542

Translation, validation and cultural adaptation of the Arabic version of the HIV knowledge questionnaire (HIV-Kq-18)

Mohamed Terra 1,2,*, Mohamed Baklola 1,2,*, Elfatih A Hasabo 3,*, Dina Gamal Shaheen 4, Abdel-Hady El-Gilany 4; ARO team of collaborators
Editor: Nour Amin Elsahoryi5
PMCID: PMC10101484  PMID: 37053199

Abstract

Background

Although the number of new HIV infections is declining in most regions of the world, the Middle East is one of the regions with a rapidly growing HIV epidemic, with Egypt having the fastest-growing epidemic, with a 76 percent increase in the number of cases. One of the major factors contributing to this trend is the general public’s lack of knowledge about the disease. The HIV Knowledge Questionnaire-18 (HIV-KQ-18) is one of the most widely used instruments for assessing HIV/AIDS knowledge and has been translated into several languages. This study examined the validity of the Arabic version of the HIV-18-KQ as well as its adaptation among Arab undergraduates.

Methods

The HIV-18-KQ was both forward and back-translated. The translation was reviewed by an expert committee of eight experts. The final version was created and distributed to undergraduates from five Arabic countries: Egypt, Sudan, Yemen, Jordan, and Algeria. The validity of the Arabic version of the HIV-18-KQ was evaluated using internal consistency and construct validity. Internal consistency was tested using the Kuder-Richardson formula 20 (KR-20), and construct validity was evaluated using an exploratory factor analysis with a polychoric correlation matrix.

Results

The majority of the translated items were easy to understand. The Arabic HIV-18-KQ was deemed culturally appropriate by the expert committee. This study included 1745 university students, including 956 (54.5%) males and 798 (45.5%) females, with 33.4% from Egypt. Based on the acceleration factor approach to interpreting the scree plot in the factor analysis, it was preferable to use only one factor, which is consistent with the original version of HIV-45-KQ. The KR-20 value was 0.73, indicating good internal reliability.

Conclusion

This study demonstrates that the Arabic version of the HIV-18-KQ is a valid and reliable tool for assessing HIV-related knowledge in Arabic-speaking countries.

Introduction

The Human Immunodeficiency Virus (HIV) and acquired immunodeficiency syndrome (AIDS) continue to be major worldwide health concerns, with intense international and local efforts to organize resources to combat the epidemic [1]. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), there would be 38.4 million HIV-positive people globally in 2021, with 650 thousand dying of AIDS-related illnesses. Furthermore, it is estimated that one in six people with HIV (15%) are still unaware they are infected [2]. The Sustainable Development Goals (SDGs) sparked a coordinated global effort to combat HIV/growing AIDS prevalence [3,4]. To combat the increased prevalence of HIV, more proactive initiatives with preventative education are urgently needed, and the global community must evaluate the SDGs’ progress throughout all globe areas [3].

Although the HIV pandemic is witnessing a decline in the number of new infections in most regions of the world, the Middle East and North Africa Region (MENA) is one of the regions of the world with a rapidly increasing HIV epidemic [5]. Egypt has a relatively low estimated number of people living with HIV, which was approximately 11,000 by the end of 2016, relative to the total population. However, the country is experiencing the fastest-growing epidemic in the Middle East and North Africa Region (MENA), with a 76% increase in the number of cases between 2010 and 2016 [6]. This alarming trend is further highlighted by the annual increase in the number of newly confirmed cases, which is between 25–30%. These worrying signs indicate a dire need for increased investments to prevent further epidemic growth and avoid the failure of controlling the epidemic [6]. Behavioral change provides the ultimate and cheapest protection against HIV infection, notwithstanding good advances in HIV therapy, because there is no cure or vaccine for HIV, and people with less HIV knowledge are more likely to participate in risky behaviors [7]. Unfortunately, data on the population’s level of knowledge of HIV and trends in the region is poor, under-reporting is likely, and exact figures or the specific causes of them are challenging to obtain [5].

A lack of Arabic-language tools for testing and measuring HIV knowledge could explain this under-reporting in describing knowledge levels. The HIV Knowledge Questionnaire (HIV-KQ-18) instrument has been shown to be a valid, reliable (Cronbach’s alpha at 0.75–0.89), stable, sensitive, and appropriate instrument for all people, including those with low literacy levels [8]. HIV-KQ-18 is available in a wide range of languages and has been used in a variety of contexts, including Spanish, Greek, and Indonesian [9,10]. There have been no studies that thoroughly adapt and validate this instrument for the Arab adult population. As a result, the objective of this study was to translate, validate, and adapt the HIV-KQ-18 instrument on university students in our MENA region.

Methods

Sampling and procedures

Participants were university students between the age group of 18 and 25. They were from five Arab nations; Algeria, Egypt, Sudan, Yemen, and Jordan. These five countries represent a diverse range of cultures, traditions, and beliefs throughout the Middle East and North Africa.

In each country, a team of data collectors was assembled. This group received standardized instruction on how to approach Students online. From May 2022 to June 2022, each collaborator oversaw the collection of responses by posting the questionnaire on official student social media groups from all academic years in order to reach all students.

Participants completed an anonymous online questionnaire that was processed using Google Form to guarantee a broad reach and ease of use. Participants chose to take part willingly and without remuneration.

There are no precise standards for the sample size required to validate or study tools due to the wide variety of tools and the number of items they contain. The rule of thumb has been at least 10 participants for each scale item, implying that a 10.1 ratio of respondents to items is ideal [11]. Because the instrument has 18 items, the minimum sample size required is 180 students, which is then multiplied by 5 for the design effect, for a total sample of 900. Since larger samples are usually preferable to smaller ones, when conducting exploratory factor analysis, a total sample of 1745 was collected [12].

Instrument

The instrument contained the HIV-KQ-18 [10] and sociodemographic variables. HIV-KQ18 is a shortened form of HIV-KQ-45. Professor Michael P. Carey, Ph.D. granted permission to use and translate the HIV-KQ-18 instrument (Director of Miriam Hospital’s Center for Behavioral and Preventive Medicine). The HIV-KQ-18 instrument is more oriented toward HIV/AIDS infection and transmission prevention. Each of the 18 items on this instrument has three options: "true," "false," or "don’t know." Five of the items are true (items number: 1, 4, 11, 14, and 17), whereas the other 13 are false. The correct response receives a 1, whereas incorrect or "don’t know" answers receive a 0.

The collected sociodemographic data included sex, age, marital status, nationality, residence, and field of study. Participants were divided into two groups according to whether they have a medical educational background (Medicine, Pharmacy, Nursing, or Dentistry) or not.

They were informed that the data submitted from the questionnaire would be anonymous, confidential, and used only for research purposes in order to protect confidentiality. Also, access to the dataset was restricted to researchers.

Arabic translation of HIV-KQ 18

Two independent linguists translated the English version into Arabic, and the two versions were compared to come to an agreed-upon starting version. From a linguistic standpoint, this first version was revised (S1 Appendix).

To confirm the correctness of the translation and the consistency of the synonyms, the Arabic version was retranslated into English by two additional linguists who were ignorant of the original English version.

Questionnaire validity

A jury of eight experts in public health and microbiology assessed the content validity. The Arabic version of the scale was evaluated for clarity, relevance, and content translation. The experts were asked to review each item separately using a three-point ordinal scale regarding clarity and relevance while translation using correct or incorrect. They were asked to give suggestions if they found them incorrect. The content validity index (CVI) was determined at three levels: item (I-CVI), expert (E-CVI), and scale (S-CVI) [13]. To calculate the CVI at the item level (I-CVI), divide the number of experts who rated the item as relevant or clear (rating 3) by the total number of experts. The CVI per expert (E-CVI) was determined by dividing the number of items rated by three. The item was appropriate if the CVI was greater than 0.79. It needs to be revised if it was between 0.70 and 0.79. It was deleted if it was less than 0.70. The CVI for the full scale (SCVI) was calculated using the S-CVI, by adding all I-CVI for relevancy divided by the number of items. If S-CVI was more than or equal to 0.90, the scale was considered valid as a tool [14]. An overview of the entire study process is shown in Fig 1.

Fig 1. Adaptation and validation of HIV-KQ-18 for Arabic population.

Fig 1

Reliability and factor analysis

Internal consistency was tested using the Kuder-Richardson formula 20 (KR-20) as all items employed a dichotomous response [15]. KR-20 score above 0.70 is generally considered to represent a reasonable level of internal consistency reliability and indicates strong item homogeneity.

Due to the dichotomous nature of HIV-KQ-18, an exploratory factor analysis (EFA) with a polychoric correlation matrix was used to examine construct validity [16,17].

The number of factors that might be retained was determined using eigenvalues, parallel analysis, optimal coordinates, and acceleration factor to eliminate subjectivity in reading the scree plot. If these parameters provided opposing recommendations for the number of factors to retain, other considerations were used, such as the feasibility of interpreting underlying factors [13].

All statistical analyses were carried out with SPSS version 25 (IBM Corp., Armonk, New York, USA), R version 4.1.0, and R Studio Version 1.4.1717 using the polycor, n Factors, validate R, and EFA.dimensions packages. The statistical significance level was set at P-value < 0.05.

Ethics approval and consent to participate

The study proposal was approved by the Institutional Review Board (IRB) of Mansoura University’s Faculty of Medicine, with the proposal code R.22.04.1683.R1. Google Form was used to conduct an anonymous online questionnaire submitted by participants. Participants participated voluntarily and without compensation. All methods were carried out in accordance with the relevant ethical guidelines and regulations. On the first page of the online form, participants were informed that by filling the questionnaire, they were giving us permission to use the data for research purposes (Informed Consent) and that they had the option to stop filling out the form at any time. So, after being told what the questionnaire was for, all of the participants who filled it out granted their permission.

Results

Participant characteristics

There were 1754 participants from five Arab countries. All the participants were between the ages of 17 and 25, with the majority being male (54.5%), single (83.5%), Egyptian (33.4%), urban (80.7%), and studying health-related sciences (57.6%). Table 1 contains detailed sociodemographic information about the participants.

Table 1. Participants’ characteristics.

Variables n Percent
Age
17–20 302 17.2
21–23 737 42
24–25 715 40.8
Sex
Female 798 45.5
Male 956 54.5
Martial Status
Single 1465 83.5
Engaged 97 5.5
Married 192 10.9
Nationlity
Algeria 339 19.3
Egypt 585 33.4
Sudan 414 23.6
Jordan 209 11.9
Yemen 207 11.8
Field of Study
Non-Medical Education 744 42.4
Medical Education 1010 57.6
Residence
Rural 338 19.3
Urban 1416 80.7
Total Participants 1754 100

Validity

Table 2 shows that the I-CVI ranged from 0.91 to 1.0 in different items of both relevance and clarity. While the E-CVI ranged from 0.92 to 1.0 in different items of both relevance and clarity. The S-CVIs were 0.98 for relevance and clarity.

Table 2. Content validity indices.

Item I-CVI for relevance I-CVI for clarity Expert E-CVI for relevance E-CVI for clearance
1 1 1 1 1 1
2 1 1 2 1 1
3 1 0.91 3 1 1
4 0.96 1 4 1 1
5 0.92 0.96 5 0.92 0.96
6 0.92 0.96 6 0.92 0.94
7 1 1 7 1 0.96
8 1 0.92 8 1 1
9 0.92 1
10 1 1
11 1 1
12 1 1
13 0.96 1
14 1 1
15 1 1
16 1 0.96
17 1 1
18 1 1
S-CVI/Ave 0.98 0.98
S-CVI/UA 0.72 0.77

Cultural adaptation

Following the pilot study and jury, we conducted rounds of evaluation for content relevance and cultural background debugging. It is recommended to replace the word “Penis” with the word “Male genital organ” which is a less intense and culturally appropriate word in Arab countries.

Recommendations from the pilot study indicated that most people are unfamiliar with the HIV virus but are familiar with AIDS; as a result, we made a point to emphasize that HIV is the cause of AIDs, which is widely known among Arabs.

Item analysis

The percentage of correct answers and the Corrected Item-Total Correlation are shown in Table 3. In terms of difficulty, questions 12 and 15 were the most difficult, while questions 14 and 1 were the easiest. Most participants correctly answered Question 14 (94.8 percent). However, item 12 proved to be the most difficult, with less than 30% of participants correctly answering it (15.2 percent).

Table 3. Item analysis of HIV-KQ-18 Arabic version.

Item Percentage of Correct Answers Corrected Item-Total Correlation
Q1 77.10% 0.249
Q2 69.70% 0.336
Q3 51.70% 0.334
Q4 69.00% 0.284
Q5 61.60% 0.397
Q6 45.30% 0.243
Q7 56.60% 0.356
Q8 62.30% 0.391
Q9 37.90% 0.233
Q10 62.20% 0.45
Q11 40.40% 0.255
Q12 15.20% 0.225
Q13 73.70% 0.467
Q14 94.80% 0.18
Q15 31.90% 0.301
Q16 51.10% 0.389
Q17 49.90% 0.102
Q18 36.70% 0.372

There was a range of 30 to 80 in the percentage of correct answers for the other 16 items, so they were acceptable. Correlations were less than 0.3 for eight items (numbers 1, 4, 6, 9, 11, 12, 14, and 17), while only five items (numbers 6, 9, 12, 14, and 17) were less than 0.25 in their corrected item totals. Item 17 has the fewest correlations.

Factor analysis

Only five factors could be retained in the EFA based on eigenvalues, one factor based on parallel analysis, optimal coordinates, and the acceleration factor as shown in Fig 2. There were some difficulties in interpreting five factors on eigenvalues because the cross-loading of some items made it difficult. As a result, one factor with 17 items was retained from the EFA with an RMSEA value of 0.135. There were no items with loading factors lower than 0.30. Reliability is indicated by the KR-20 Coefficient of 0.73 for this factor. The details of the EFA are presented in Table 4.

Fig 2. The non-graphical solution of Scree plot to determine the number of factors to be retained.

Fig 2

Table 4. Factor analysis of HIV-KQ-18 Arabic version.

Item Factor loading KR-20 Coefficient
Q1 0.41 0.733
Q2 0.52
Q3 0.47
Q4 0.4
Q5 0.59
Q6 0.35
Q7 0.51
Q8 0.6
Q9 0.39
Q10 0.66
Q11 0.36
Q12 0.41
Q13 0.74
Q14 0.41
Q15 0.47
Q16 0.57
Q17 0.3
Q18 0.55

Discussion

Currently, there is no validated Arabic tool for assessing the general public’s knowledge of HIV. Many studies have been conducted in Arabic countries to assess the knowledge about HIV, but most of them either used the English version of HIV-18 KQ [18] or developed an Arabic tool to assess the knowledge, but their tool wasn’t tested on a large scale to assess its validity and reliability [19]. As a result, ours is the first study to translate, validate, and adapt the HIV-18 KQ in the Arabic community.

Content validity can be tested in a variety of ways, one of them is Content Validity Index (CVI) which we used to quantify content validity and it is also the most commonly used method.

Since an average score of Item-level CVI (I-CVI) can be skewed by outliers, therefore this paper looked at the I-CVI, expert-level CVI (E-CVI), and scale CVI (S-CVI) [20].

The number of experts (n = 8) was deemed sufficient for content validation [21]. A minimum I-CVI score of 0.78 is regarded as excellent. Individual items were determined to be important and relevant for measuring content validity. Any S-CVI value between 0.80 and 0.90 is regarded as minimally acceptable [20,21]. In the current study, the relevance and clarity scores for I-CVI, E-CVI, and S-CVI ranged between 0.9 and 1.0.

Our findings suggest that the HIV-KQ-18 Arabic Version is a reliable and valid instrument for use in various Arabic-speaking countries. The adaptation phase of the instrument began with a pilot test, which revealed that all items were clear to participants and there was no difficulty comprehending the translated items. Then we distributed the instrument to our participants. As a result, we extended the instrument’s usage to general undergraduates versus prior studies that mainly utilized the tool in its English version on Arab medical students [18].

The number of factors that should be maintained in order to ensure construct validity varies depending on the specifics of the situation. We chose to keep one factor based on the parallel analysis and acceleration factor from the scree plot, which is consistent with the original HIVKQ-45, which suggested only one factor labeled HIV knowledge [22]. Although additional studies are required, we believe the structural validity of the HIV-KQ18 is acceptable. The corrected item-total correlation indicates that the correlation was less than 0.2 for question 14 and 17, which may indicate that the questions are not discriminating well in our study setting [23]. The questions concern the mode of transmission, the type of sex act, and a change in a sex partner, which are all uncommon in our nations, since culture, law, and religion in the Arab world all support normal sexual relations with a single partner.

In our study, 94.8 percent of participants correctly answered question 14, indicating that the majority of participants believed HIV/AIDS was closely linked to sexual activity with more than one partner. However, more than half of the participants still believe that deep kissing with an HIV-positive partner does not transmit HIV and that using Vaseline or baby oil with condoms can reduce the risk of contracting HIV even though deep kissing and Vaseline oil do transmit the virus. Our study has both strengths and drawbacks. Over a thousand people from five different Arab countries took part in this first-of-its-kind study to adapt and validate HIV-KQ-18 for use in the Arab community. The first drawback, the study was conducted using an online method, which may have made the measure inaccessible to some individuals and susceptible to self-selection bias. Second, participants were only recruited from university students with Internet access. Therefore, they did not adequately represent the entire population. Future studies involving more diverse samples of all ages and literacy levels would aid in establishing the validity and utility of the HIV-18 KQ Arabic version. Thirdly, test-retest and inter-rater reliability, as well as the sensitivity and specificity of the scale, were not investigated.

Conclusion

The HIV-18 KQ is a widely used tool with numerous translations around the world. The Arabic version of the HIV-18 KQ is a valid and reliable tool for assessing HIV knowledge. We hope that our study will inspire researchers to conduct additional studies in all Arabic-speaking countries for all age groups and literacy levels.

Supporting information

S1 Appendix. Arabic version of the HIV knowledge questionnaire (HIV-Kq-18).

(DOCX)

Acknowledgments

I’d like to thank the linguists that translate the tool both forward and backward (Lina Muneer, Hussien Faied, Nour Fakih, Ahmed Elrashed).

Alpha Research Organization (ARO) team of collaborators: Rais Mohammed Amir, Judy Bassiouny, Emad Addin Zawaneh, Asmaa Mohamed Abbas, Laith Shakhatreh, Enas Elshabrawy, Buthaina Ameen.

Data Availability

The datasets used and/or analysed during the current study are available from the following DOI link: https://doi.org/10.6084/m9.figshare.22236550.v1.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Govender RD, Hashim MJ, Khan MA, Mustafa H, Khan G. Global Epidemiology of HIV/AIDS: A Resurgence in North America and Europe. J Epidemiol Glob Health. 2021;11: 296–301. doi: 10.2991/jegh.k.210621.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Global HIV & AIDS statistics—Fact sheet | UNAIDS. [cited 8 Aug 2022]. Available: https://www.unaids.org/en/resources/fact-sheet.
  • 3.Mabaso MLH, Zama TP, Mlangeni L, Mbiza S, Mkhize-Kwitshana ZL. Association between the Human Development Index and Millennium Development Goals 6 Indicators in Sub-Saharan Africa from 2000 to 2014: Implications for the New Sustainable Development Goals. J Epidemiol Glob Health. 2018;8: 77–81. doi: 10.2991/j.jegh.2018.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.The AIDS response in the 2030 agenda for sustainable development: joint work, shared gains | UNAIDS. [cited 13 Aug 2022]. Available: https://www.unaids.org/en/AIDS_SDGs.
  • 5.Gökengin D, Doroudi F, Tohme J, Collins B, Madani N. HIV/AIDS: trends in the Middle East and North Africa region. Int J Infect Dis. 2016;44: 66–73. doi: 10.1016/j.ijid.2015.11.008 [DOI] [PubMed] [Google Scholar]
  • 6.WHO EMRO | Egypt HIV country profile | Country activities | AIDS and sexually transmitted diseases. [cited 8 Aug 2022]. Available: http://www.emro.who.int/asd/country-activities/egypt-hiv-country-profile.html.
  • 7.Peteet B, Staton M, Miller-Roenigk B, Carle A, Oser C. Rural Incarcerated Women: HIV/HCV Knowledge and Correlates of Risky Behavior. Health Educ Behav. 2018;45: 977–986. doi: 10.1177/1090198118763879 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Carey MP, Schroder KEE. Development and Psychometric Evaluation of the Brief HIV Knowledge Questionnaire. AIDS Educ Prev. 2002;14: 172. doi: 10.1521/aeap.14.2.172.23902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Arifin B, Rokhman MR, Zulkarnain Z, Perwitasari DA, Manggau M, Rauf S, et al. Adaptation and validation of the HIV Knowledge Questionnaire-18 for the general population of Indonesia. Health Qual Life Outcomes. 2022;20: 1–12. doi: 10.1186/S12955-022-01963-5/FIGURES/3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Carey MP, Schroder KEE. Development and Psychometric Evaluation of the Brief HIV Knowledge Questionnaire. AIDS Educ Prev. 2002;14: 172. doi: 10.1521/aeap.14.2.172.23902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nunnally JC. Psychometric theory. New York: McGraw-Hill; 1978. [Google Scholar]
  • 12.Costello AB, Osborne J. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Practical Assessment, Research, and Evaluation. 2019;10: 7. 10.7275/jyj1-4868. [DOI] [Google Scholar]
  • 13.Ruscio J, Roche B. Determining the number of factors to retain in an exploratory factor analysis using comparison data of known factorial structure. Psychol Assess. 2012;24: 282–292. doi: 10.1037/a0025697 [DOI] [PubMed] [Google Scholar]
  • 14.Polit DF, Beck CT. The content validity index: Are you sure you know what’s being reported? critique and recommendations. Res Nurs Health. 2006;29: 489–497. doi: 10.1002/nur.20147 [DOI] [PubMed] [Google Scholar]
  • 15.Kuder GF, Richardson MW. The theory of the estimation of test reliability. Psychometrika 1937 2:3. 1937;2: 151–160. doi: 10.1007/BF02288391 [DOI] [Google Scholar]
  • 16.Barendse MT, Oort FJ, Timmerman ME. Using Exploratory Factor Analysis to Determine the Dimensionality of Discrete Responses. https://doi.org/101080/107055112014934850. 2014;22: 87–101. doi: 10.1080/10705511.2014.934850 [DOI]
  • 17.Muñoz-Quezada MT, Lucero B, Castillo B, Bradman A, Zúñiga L, Baumert BO, et al. Psychometric Validation of a Questionnaire to Assess Perception and Knowledge About Exposure to Pesticides in Rural Schoolchildren of Maule, Chile. Front Psychol. 2021;12: 4069. doi: 10.3389/fpsyg.2021.715477 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Knowledge, Attitudes, and Beliefs about HIV/AIDS and People Living with HIV among Medical Students at Qassim University in Saudi Arabia. [PMC free article] [PubMed]
  • 19.Ali RA. Knowledge and Attitude of Nursing Students about HIV/AIDS in Sohag, Egypt. Journal of High Institute of Public Health. 2020. [Google Scholar]
  • 20.Polit DF, Beck CT. The content validity index: Are you sure you know what’s being reported? critique and recommendations. Res Nurs Health. 2006;29: 489–497. doi: 10.1002/nur.20147 [DOI] [PubMed] [Google Scholar]
  • 21.Yamada J, Stevens B, Sidani S, Watt-Watson J, de Silva N. Content Validity of a Process Evaluation Checklist to Measure Intervention Implementation Fidelity of the EPIC Intervention. Worldviews Evid Based Nurs. 2010;7: 158–164. doi: 10.1111/j.1741-6787.2010.00182.x [DOI] [PubMed] [Google Scholar]
  • 22.Carey MP, Morrison-Beedy D, Johnson BT. The HIV-Knowledge Questionnaire: Development and Evaluation of a Reliable, Valid, and Practical Self-Administered Questionnaire. AIDS Behav. 1997;1: 61–74. doi: 10.1023/A:1026218005943 [DOI] [Google Scholar]
  • 23.Rao C, Prasad HK, Sajitha K, Permi H, Shetty J. Item analysis of multiple choice questions: Assessing an assessment tool in medical students. International Journal of Educational and Psychological Researches. 2016;2: 201. doi: 10.4103/2395-2296.189670 [DOI] [Google Scholar]

Decision Letter 0

Nour Amin Elsahoryi

27 Feb 2023

PONE-D-23-01822Translation, Validation and cultural adaptation of the Arabic version of the HIV knowledge questionnaire (HIV-Kq-18)PLOS ONE

Dear Dr. Hasabo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 13 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Nour Amin Elsahoryi, pHD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. One of the noted authors is a group or consortium: Alpha Research Organization (ARO) team of collaborators 

In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

6. Please upload a copy of Figure 1 and 2, to which you refer in your text on page 8 and 10. If the figure is no longer to be included as part of the submission please remove all reference to it within the text.

7. Please ensure that you refer to Figure 3 and 4 in your text as, if accepted, production will need this reference to link the reader to the figure.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript ‘Validation and cultural adaptation of the Arabic version of the HIV knowledge questionnaire (HIV-Kq-18)’ addresses an interesting problem in the use of HIV-18 KQ. Although there are some points and concepts need to be fixed in order to be acceptable for publishing (see the attachment).

Reviewer #2: The paper titled “Translation, Validation and cultural adaptation of the Arabic version of the HIV knowledge questionnaire (HIV-Kq-18)” seemed a statistically solid paper, however more discussion on the problem background and the tools applied are warranted.

Below are some comments to the authors:

• In the abstract background and on line 88 in the introduction, please provide the actual number of cases in addition to the percentage provided and also specify the time period.

• In the abstract, please, mention the validity metrics used to assess the questionnaire validity.

• Please, add reference for lines 121-122.

• A typo on line 132.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.<quillbot-extension-portal></quillbot-extension-portal>

Attachment

Submitted filename: PONE-D-23-01822-Re.pdf

PLoS One. 2023 Apr 13;18(4):e0284542. doi: 10.1371/journal.pone.0284542.r002

Author response to Decision Letter 0


14 Mar 2023

Dear reviewers,

The following are the responses to your comments.

Respond to reviewer 1

We would like to thank reviewer 1 for all his effort during reviewing our manuscript.

Specific Responses:

Comments:

• Line 118: “implying that a 10:1 ratio” must be changed by “implying that a 10.1 ratio”

• Line 174: “RStudio Version” must be changed by “R Studio Version”

• Line 174: “nFactors” must be changed by “n Factors”

• Line 175: “validateR” must be changed by “validate R”

• In page 19 the figure named “Adaptation and Validation of HIV-KQ-18 for Arabic Population” is Figure 1 not 3.

• In page 20 the figure named “The non-graphical solution of Scree plot to determine the number of factors to be retained” is Figure 2 not 4.

• In page 21 the table named “Participants’ characteristics” is Table 1 not 3.

• In page 18 the “Table 2: Factor analysis of HIV-KQ-18 Arabic Version” must be Table 4: Factor analysis of HIV-KQ-18 Arabic Version.”

Reply: The required amendments were done. Also, we uploaded Arabic version of the HIV knowledge questionnaire as a supplementary appendix.

Respond to reviewer 2

We would like to thank reviewer 2 for all his effort during reviewing our manuscript.

Specific Responses:

Comment 1: “

• In the abstract and background on line 88 in the introduction, please provide the actual number of cases in addition to the percentage provided and also specify the time period.

• In the abstract, please, mention the validity metrics used to assess the questionnaire validity.

• Please, add reference for lines 121-122.

• A typo on line 132.”

Reply:

• We clarified this in the introduction section by adding a paragraph from line 87 – 94 and made it as requested.

• We mentioned the validity metrics from line 59 to 63 in the methods section of the abstract.

• We added a reference to lines 121 – 122.

• We rephrase the sentence on line 132.

• Also, we uploaded Arabic version of the HIV knowledge questionnaire as a supplementary appendix.

Sincerely,

Elfatih A. Hasabo

Attachment

Submitted filename: Point-by-point response to reviewers of round 1.docx

Decision Letter 1

Nour Amin Elsahoryi

3 Apr 2023

Translation, Validation and cultural adaptation of the Arabic version of the HIV knowledge questionnaire (HIV-Kq-18)

PONE-D-23-01822R1

Dear Dr, 

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nour Amin Elsahoryi, pHD

Academic Editor

PLOS ONE

<quillbot-extension-portal></quillbot-extension-portal>

Acceptance letter

Nour Amin Elsahoryi

5 Apr 2023

PONE-D-23-01822R1

Translation, Validation and cultural adaptation of the Arabic version of the HIV knowledge questionnaire (HIV-Kq-18)

Dear Dr. Hasabo:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nour Amin Elsahoryi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Arabic version of the HIV knowledge questionnaire (HIV-Kq-18).

    (DOCX)

    Attachment

    Submitted filename: PONE-D-23-01822-Re.pdf

    Attachment

    Submitted filename: Point-by-point response to reviewers of round 1.docx

    Data Availability Statement

    The datasets used and/or analysed during the current study are available from the following DOI link: https://doi.org/10.6084/m9.figshare.22236550.v1.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES